Abivax's IPO to fund HIV and hep B pipeline before potential Big Pharma deal
In France’s largest ever biotech IPO, Abivax has raised €58m ($64m) to continue developing its HIV and Hep B candidates.
In France’s largest ever biotech IPO, Abivax has raised €58m ($64m) to continue developing its HIV and Hep B candidates.
GSK’s HIV unit ViiV Healthcare and China-based Desano Pharmaceuticals have forged an agreement whereby Desano will manufacture the API of GSK’s HIV drug Tivicay (dolutegravir) in China.
A group calling for GMP assessments to consider the environmental impact of API production says pollution generated by suppliers in China is furthering the spread of resistant superbugs.
Toronto-based Attix Pharmaceuticals has received a US FDA warning letter after an inspection from November and a lack of corrective actions in the company’s response to the FDA.
UPDATE
Indian CRO Quest Life Sciences has been hit with a Notice of Concern (NOC) after the WHO questioned the data integrity of its clinical records.
The world’s second-largest central lab services company is now operational, with Quintiles and Quest Diagnostics calling their new creation Q2 Solutions.